Literature DB >> 10627496

HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1).

D Stroup1, J Y Chiang.   

Abstract

The gene for cholesterol 7alpha-hydroxylase (CYP7A1) contains a sequence at nt -149 to -118 that was found to play a large role in determining the overall transcriptional activity and regulation of the promoter. Hepatocyte nuclear factor 4 (HNF4) and chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) synergistically activate transcription of the CYP7A1 promoter. Transactivation of CYP7A1 by HNF4 in the human hepatoma cell line, HepG2, was enhanced by cotransfection with COUP-TFII or the basal transcription element binding protein (BTEB). HNF4 prepared from rat liver nuclear extracts bound to oligomers homologous to the nt -146 to -134 sequences in electrophoretic mobility shift assays (EMSA), which corresponded to a conserved region containing a direct repeat of hormone response elements spaced by one nucleotide (DR1). The sequences surrounding this DR1 were found to be essential for the HNF4 transactivation. In vitro-translated COUP-TFII was found to bind the adjacent sequences from nt -139 to -128 (DR0), but COUP-TFII interacted with this region at a much lower affinity than to the COUP-TFII-site at nt -72 to -57 (DR4). Mutations at nt -139 to -128 or nt -72 to -57 reduced the COUP-TFII and HNF4 synergy; however, these COUP-TFII-binding sequences were not absolutely required for the cooperative effect of HNF4 and COUP-TFII on transactivation. These results indicated that the observed transactivation was the result of protein/protein interactions facilitated by the juxtaposition of the binding elements.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627496

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  46 in total

Review 1.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

2.  Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells.

Authors:  Tiangang Li; Asmeen Jahan; John Y L Chiang
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

Review 3.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

Review 4.  Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.

Authors:  John Y L Chiang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

5.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 6.  COUP-TFII revisited: Its role in metabolic gene regulation.

Authors:  Usman M Ashraf; Edwin R Sanchez; Sivarajan Kumarasamy
Journal:  Steroids       Date:  2018-11-24       Impact factor: 2.668

7.  Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration.

Authors:  Lisheng Zhang; Xiongfei Huang; Zhipeng Meng; Bingning Dong; Steven Shiah; David D Moore; Wendong Huang
Journal:  Mol Endocrinol       Date:  2008-12-04

8.  Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes.

Authors:  G P Laliotis; I Bizelis; E Rogdakis
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

9.  Involvement of transcription factor NR2F2 in human trophoblast differentiation.

Authors:  Michael A Hubert; Susan L Sherritt; Cindy J Bachurski; Stuart Handwerger
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

10.  Molecular characterization of SMILE as a novel corepressor of nuclear receptors.

Authors:  Yuan-Bin Xie; Balachandar Nedumaran; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.